USPTO serial 79401298
AVANCE CLINICAL THE CRO FOR BIOTECHS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 21, 2025
- Examiner
- LAVACHE, LINDA M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AVANCE CLINICAL THE CRO FOR BIOTECHS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
AU
AU
AU
AU
AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David L. May
David L. May Nixon Peabody LLP799 9th Street, NW, Suite 500Washington, DC 20001United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business statistical analysis; business statistical studies; compilation of statistics for business purposes; data collection for biotechnology and pharmaceutical companies for business purposes; data compilation for others for business purposes; data management services, namely, business information management services for use by biotechnology and pharmaceutical companies for business purposes; data management advice, namely, providing advice in the field of business information management; data management consultancy, namely, consultancy in the field of business information management; data processing services, namely, database management; data capture, namely, computer data entry services; data cleansing services, namely, computer data entry services in the nature of correcting or removing inaccurate or incomplete data from databases; Data processing services, namely, updating and maintenance of data in computer databases; Data processing services, namely, data systemization in computer databases; data processing; data processing verification; Data processing services, namely, data retrieval; Data processing services, namely, data transcription, namely, computer data entry services; demand-based computerised data processing | ACTIVE | — |
| 042 | Advisory services relating to pharmacology; advisory services relating to product testing; advisory services relating to science in the field of pharmacology; advisory services relating to scientific research; development of software systems for the processing of data; development of testing methods in the field of pharmacology; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others in the field of pharmacology; conducting technical project studies, namely, conducting scientific feasibility studies in the field of pharmacology; consultancy pertaining to pharmacology; medical research; pharmaceutical research services; preparation of reports relating to scientific research; preparation of statistics for scientific research, namely, preparation of technical reports and analyses of statistical data for scientific research; provision of information relating to scientific research; Product quality testing; research relating to biotechnology; scientific research relating to data processing; research relating to medicine; research relating to pharmaceuticals; scientific and technical analysis in the field of pharmacology; scientific consultancy services relating to pharmacology; scientific testing services in the field of pharmacology; pharmaceutical testing services for assessing the efficiency of pharmaceuticals; pharmaceutical testing services for assessing the safety of pharmaceuticals; technical data analysis services in the field of pharmacology for scientific research purposes; testing of products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Avance Clinical Pty Ltd
- Other trademarks owned by Avance Clinical Pty Ltd
- Other trademarks owned by Avance Clinical Pty Ltd
- Other trademarks owned by Avance Clinical Pty Ltd
- Other trademarks owned by Avance Clinical Pty Ltd
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named AVANCE CLINICAL THE CRO FOR BIOTECHS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 28, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 7, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 7, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 21, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 15, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 31, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 31, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 21, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 21, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 2, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 2, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 27, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 28, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 28, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 28, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 28, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 28, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 29, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 29, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 29, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 6, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 6, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 6, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 25, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 4, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 4, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 17, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 16, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 9, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 13, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 6, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 6, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 1, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |